Professor Mikhail Blagosklonny Has Made Great Advancements In The Field Of Cancer Research

As a qualified scientist and medical researcher, Mikhail Blagosklonny has managed to establish himself in the field of medicine. Mr. Mikhail has a diversified portfolio in medicine. He wears different crowns as a doctor, a medical researcher, a university don, an editor and a writer in the industry of medicine.Professor Mikhail is of Russian descent. Dr. Mikhail trained as a medical expert in Russia and went through the prestigious First Pavlov State Medical University in Experimental Medicine and Cardiology. He also boasts of an M.D. in the discipline of Internal Medicine from the same university.Dr. Mikhail Blagosklonny’s settlement in the United States came after he had completed his higher education. The professor settled in the New York City in the year 2002 and started building his career. While in New York, Mikhail joined the New York Medical College fraternity and became a valuable member of the establishment. At the institution, Mikhail began his career as an associate professor of medicine. After diligently serving in this position for a few years, he proceeded to the Ordway Research Institute in the capacity of Senior Scientist. His new post gave him an opportunity to delve into medical research as a full-time preoccupation.

At Ordway Research Institute, Dr. Mikhail chose to focus his experiments on cancer. To actualize his dreams of coming up with significant findings in the field of oncology, Mikhail affiliated himself with the Roswell Park Cancer Institute. Later, he was fully enjoined as a distinguished professor of oncology at the institution. To date, Mikhail Blagosklonny is a valuable member of the Roswell Cancer Institute.The medical don has dedicated a significant part of life in ensuring that milestones are made in the quest for efficient cancer treatments. His focus in medical research lies with two disciplines, Oncology and Biogerontology. Over the period of his work, Mikhail Blagosklonny has been able to cover the subject of anti-aging extensively with the aim of understanding the process of aging and being able to come up with remedies that slow down this process. In the course of his work, Mikhail has been able to draw the relationship between cancer and aging.

Mikhail’s primary objective has always been to come up with drugs that can halt the process of aging.Mikhail Blagosklonny dedicates a lot of time to his research work. His expertiseand experience have enabled him to come up with a medical journal that is soaring in popularity among communities. The journal is called Oncotarget, and it publishes findings in the field of cancer research, theories and expert opinions. Prof. Mikhail is one of the senior editors of the publications.Prof. Mikhail Blagosklonny is not only known as the editor of Oncotarget but also as a researcher who has contributed immensely to the innovation of modern solutions to the aging and cancer problems. Dr. Mikhail is undeniably a jewel in the field of oncology. He is one of the experts who is always called on to provide expert opinions on matters that deal with cancer and aging.

Lori Senecal – A True Global Leader That’s Creative and Encourages Innovation

Lori Senecal is one of the well-known names in the marketing and advertising field in the U.S. and is currently the Global CEO of Crispin Porter+Bogusky, commonly referred to as CP+B. She holds the degree of Bachelor of Commerce in marketing and finance from McGill University. Lori has a very successful career in the marketing and advertising field and is known as one of the most enthusiastic, experienced and creative figures in the industry. See, http://www.adweek.com/news/advertising-branding/lori-senecal-named-president-ceo-mdc-partner-network-159416.

She started her career as an entrepreneur by co-founding a company named TAG Ideation in 2003, where she remained involved until 2006 when she joined McCann Worldgroup as Global Chief Innovation Officer. Due to her accomplishments, performance and overall diligence towards her work, she was promoted to the President of McCann Erickson in July 2007.

After working for over two years with McCann, Lori in her endeavor to make her mark in the marketing field joined Kirshenbaum Bond Senecal +Partners as President and CEO in 2009. By March 2012, she became the chairman and CEO of Kirshenbaum Bond Senecal +Parnters. Currently, she holds the position of Chairman and CEO of Kirshenbaum Bond Senecal +Partners and is also the Global Executive Chairman of the company. She holds the position of President and CEO of MDC Partners and as mentioned before is also the Global CEO of CP+B.

However as Huffington Post describes in an article, even after having so many responsibilities on her shoulders, Lori Senecal is a tough nut to crack and is fairly competitive, yet friendly and professional to the core. With CP+B as Global CEO, she is responsible for managing, monitoring and helping nine international offices of the company to grow and expand. Due to her vast experience, distinctive personality, a keen eye for detail and agility, she has been able to influence the business of the company positively, but also made the CP+B a truly global company that is deep-rooted in the local markets as well.

Lori Senecal in 2014 was named the Ad Age’s Women to Watch and was given the award of Quantum Leap in 2013 at AWNY Game Changer Awards. To encourage new talent in the industry, and promote them career wise, she also founded Isaac+ Awards that celebrates invention by students. Even after having many feathers on her cap already, she seems unstoppable and is mostly certainly a leader to watch out for in marketing and advertising segment. View her crunchbase profile for more information.